Results 11 to 20 of about 35,674 (297)

Prescribers’ satisfaction with delivering medications for opioid use disorder [PDF]

Substance Abuse Treatment, Prevention, and Policy, 2021
Abstract Background Expanding access to medications for opioid use disorder (MOUD), such as buprenorphine and extended release (XR) naltrexone, is critical to addressing the US opioid epidemic, but little is known about prescriber satisfaction with delivering these two types of MOUD.
Knudsen, Hannah K, Brown, Randy, Jacobson, Nora, Horst, Julie, Kim, Jee-Seon, Kim, Hanna, Madden, Lynn M, Haram, Eric, Molfenter, Todd   +8 more
openaire   +7 more sources

Statewide trends in access to medications for opioid use disorder (moud) among adolescents with opioid use disorders in Indiana [PDF]

Drug and Alcohol Dependence Reports
Purpose: Opioid use disorder (OUD) and related harms have risen among adolescents, yet access to medications for OUD (MOUD) remains limited, particularly among Medicaid-enrolled youth.
Sumedha Gupta, Katherine Schwartz, Lauren Arnold Bell, Nicole Siegal, Matthew C. Aalsma   +4 more
doaj   +2 more sources

The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review

Addiction Science & Clinical Practice, 2023
Background An emerging public health threat of methamphetamine/opioid co-use is occurring in North America, including increases in overdoses related to concomitant methamphetamine/opioid use.
Cayley Russell, Justine Law, Sameer Imtiaz, Jürgen Rehm, Bernard Le Foll, Farihah Ali   +5 more
doaj   +2 more sources

Trends in Access to Medications for Opioid Use Disorder.

JAMA Health Forum
ImportanceMedicaid, the largest payer for medications for opioid use disorder (MOUD), disenrolled more than 19.1 million individuals by March 2024 after the continuous coverage requirement ended in April 2023—a process termed Medicaid unwinding—but the impact on buprenorphine receipt remains unknown.ObjectiveTo assess the association between Medicaid ...
Gupta S, James A, Miles J, Samples H, Crystal S, Simon K.   +5 more
europepmc   +3 more sources

Availability of Medications for Opioid Use Disorder in Opioid Treatment Programs.

JAMA Netw Open
ImportanceAs the primary facilities authorized to dispense methadone, opioid treatment programs (OTPs) are a critical access point for medications for opioid use disorder (MOUD). However, research is limited on the extent to which OTPs offer a broad range of MOUD and on the characteristics of programs that provide more comprehensive medication ...
Lindenfeld Z, Cantor JH, Mauri AI, Bandara S, Suryavanshi A, Krawczyk N.   +5 more
europepmc   +3 more sources

A lifeline on wheels: perspectives of stakeholders on the implementation and impact of a mobile medications for opioid use disorder unit [PDF]

Addiction Science & Clinical Practice
Introduction Mobile health units (MHUs) providing medications for opioid use disorder (MOUD) have emerged as a critical strategy to address gaps in opioid treatment access, particularly for marginalized populations.
Augustine Kang, Amelia Bailey, Linda Hurley, Rosemarie Martin   +3 more
doaj   +2 more sources

Perspectives of substance use disorder counselors on the benefits and drawbacks of medications for opioid use disorder [PDF]

Addiction Science & Clinical Practice
Background Medications for opioid use disorder (MOUD) are among the best tools available to combat the opioid epidemic. Yet, use of MOUD among people with opioid use disorder (OUD) remains low.
Nicholas C. Cardamone, Rebecca E. Stewart, Kyle M. Kampman, Steven C. Marcus   +3 more
doaj   +2 more sources

Use of Medications for Opioid Use Disorder in Older Adults. [PDF]

Am J Prev Med
The American population diagnosed with opioid use disorder is growing, particularly those aged ≥65 years. Less than 30% of opioid use disorder patients receive medication for opioid use disorder, and even fewer older adults.Using 20% national Medicare data, beneficiaries aged over 65 years diagnosed with opioid use disorder in 2017-2022 were selected ...
Kuo YF, Westra J, Harvey EP, Raji MA.
europepmc   +3 more sources

Review of medication-assisted treatment for opioid use disorder

Journal of Osteopathic Medicine, 2022
Abstract Context The American opioid epidemic has necessitated the search for safe and effective means of treatment for opioid use disorder (OUD). Medication-assisted treatment (MAT) encompasses select medications that are proven effective treatments for OUD.
Nessreen, Ghanem, Devin, Dromgoole, Ahmad, Hussein, Richard T, Jermyn   +3 more
openaire   +3 more sources

Medication for Adolescents and Young Adults With Opioid Use Disorder [PDF]

Journal of Adolescent Health, 2021
Opioid-related morbidity and mortality have risen in many settings globally. It is critical that practitioners who work with adolescents and young adults (AYAs) provide timely, evidence-based treatment for opioid use disorder (OUD). Such treatment should include medications for opioid use disorder (MOUD), including buprenorphine, naltrexone, and ...
Kreida, Ellen C., Galagali, Preeti M., Akgül, Sinem, Chadi, Nicholas, Aalsma, Matthew C., Hadland, Scott E., Bruner, Ann, Alinsky, Rachel H., Robinson, Camille A., Wilson, J. Deanna   +9 more
openaire   +3 more sources